Champions Oncology (CSBR) Gross Profit Growth (1y) (2018 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Gross Profit Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 8.47% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 12.01% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -17.83% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.08% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 4.27% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -45.38% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 28.30% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 44.95% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 28.30% |
| Apr 30, 2026 | 38.18% |
| Jan 31, 2026 | -25.88% |
| Oct 31, 2025 | 28.25% |
| Jul 31, 2025 | -14.15% |
| Apr 30, 2025 | -24.70% |
| Jan 31, 2025 | 149.93% |
| Oct 31, 2024 | 22.32% |
| Jul 31, 2024 | 43.31% |
| Apr 30, 2024 | 17.77% |
| Jan 31, 2024 | -17.82% |
| Oct 31, 2023 | -27.54% |
| Jul 31, 2023 | -27.13% |
| Apr 30, 2023 | -13.87% |
| Jan 31, 2023 | -25.24% |
| Oct 31, 2022 | 10.70% |
| Jul 31, 2022 | 14.27% |
| Apr 30, 2022 | 40.99% |
| Jan 31, 2022 | 9.66% |
| Oct 31, 2021 | 38.10% |